Clinical significance of stanniocalcin-1 detected in peripheral blood and bone marrow of esophageal squamous cell carcinoma patients
Open Access
- 26 April 2012
- journal article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 31 (1) , 35
Abstract
Background: Stanniocalcin-1 (STC-1) is a potential marker of disseminated tumor cells (DTCs). The aim of this study was to examine STC-1 expression in peripheral blood (PB) and bone marrow (BM) of esophageal squamous cell carcinoma (ESCC) patients, and to evaluate its clinical significance. Methods: A total of 85 ESCC patients treated with radical resection were enrolled in this study. Immunohistochemistry was used to detect STC-1 protein expression in ESCC tissues. Nested RT-PCR was used to detect STC-1 mRNA expression in PB and BM. Results: There were 71 cases (83.5%) showed a higher level of STC-1 protein expression in tumor tissues than in adjacent normal tissues (P < 0.001). Furthermore, the frequencies of STC-1 mRNA expression detected in PB and BM were 37.6% (32/85) and 21.2% (18/85), respectively, and together increased sensitivity to 48.2% (41/85), which was much higher than that in patients with benign esophageal disease (5.0%, 2/40, P < 0.001). In addition, STC-1 mRNA expression either in PB or BM was correlated with lymph metastasis, advanced stage and adverse 2-year progression free survival (PFS). In a multivariate analysis using the Cox proportional hazard model, STC-1 expression in PB and/or BM was an independent unfavorable prognostic factor for ESCC, apart from lymph metastasis and clinical stage. Conclusions: STC-1 mRNA expression is a reliable marker for detection of DTCs in PB and BM of ESCC patients, and STC-1-positive DTCs may be a promising tool for diagnosis and prognosis assessment in ESCC.Keywords
This publication has 39 references indexed in Scilit:
- Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinomaOncology Reports, 2011
- Circulating tumor cells: advances in detection methods, biological issues, and clinical relevanceJournal of Cancer Research and Clinical Oncology, 2011
- Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cellsJournal of Biomedical Science, 2011
- Stanniocalcin 1 and Ovarian TumorigenesisJNCI: Journal of the National Cancer Institute, 2010
- CK19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significanceDiseases of the Esophagus, 2010
- Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cellsBreast Cancer Research, 2009
- Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significanceClinical & Experimental Metastasis, 2009
- Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detectionJournal of Experimental & Clinical Cancer Research, 2009
- Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein levelBMC Cancer, 2008
- Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomasMolecular and Cellular Endocrinology, 2004